China (Mainland)
Diamondsupplier 
High purity 99% factory price in stock Remdesivir powder CAS NO.1809249-37-3
- FOB Price: USD: 15.00-500.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Available Specifications:
Medicine Grade(1-99)KilogramMedicine Grade(100-1000)Kilogram
- Product Details
Keywords
- Remdesivir
- factory price
- High purity 99%
Quick Details
- ProName: High purity 99% factory price in stock...
- CasNo: 1809249-37-3
- Molecular Formula: C12H13N5O4
- Appearance: White powder
- Application: It can synthesize antivirals by inhi...
- DeliveryTime: in 7 days afte your payment ( in stock...
- PackAge: 1kg/bag ;5kg/drum:25KG/drum
- Port: any port in China
- ProductionCapacity: 20 Metric Ton/Month
- Purity: 99% up
- Storage: in low tempreture
- Transportation: In well-closed container, protected fr...
- LimitNum: 1 Kilogram
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Why choose us
1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin
Details
Product Information
| Product Name | Re-mdesivir |
| CAS | 1809249-37-3 |
| Molecular formula | C27H35N6O8P |
| Molecular weight | 602.58 |
| Grade | Pharmaceutical Grade |
| Color | White powder |
| Purity | 99% |
| Shelf life | 2 years |
Usage
Remdesivir is a nucleoside analogue and is an RNA-dependent RNA polymerase (RdRp) inhibitor. It can synthesize antivirals by inhibiting viral nucleic acids. A clinical Chemicalbook bed study for infection is currently in phase II. MERS-infected mice performed much better with this combination therapy, with reduced virus replication and improved lung function. Recent studies have shown that Radixivir has a certain activity in inhibiting the new crown virus
